Victory Capital Management Inc. Decreases Stake in Mettler-Toledo International, Inc. $MTD

Victory Capital Management Inc. decreased its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 8.5% in the third quarter, HoldingsChannel.com reports. The fund owned 9,900 shares of the medical instruments supplier’s stock after selling 921 shares during the period. Victory Capital Management Inc.’s holdings in Mettler-Toledo International were worth $12,153,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Versant Capital Management Inc lifted its position in Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 8 shares during the period. SJS Investment Consulting Inc. lifted its holdings in shares of Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares during the period. Salomon & Ludwin LLC purchased a new stake in shares of Mettler-Toledo International in the third quarter worth about $43,000. Root Financial Partners LLC purchased a new position in Mettler-Toledo International during the third quarter valued at approximately $42,000. Finally, MV Capital Management Inc. lifted its holdings in Mettler-Toledo International by 50.0% in the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 12 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the transaction, the chief financial officer owned 5,288 shares in the company, valued at $7,456,714.56. This represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.94% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

MTD has been the topic of a number of analyst reports. Morgan Stanley dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 10th. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Finally, Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price on the stock in a research note on Monday, December 15th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $1,435.42.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,228.64 on Thursday. The business’s 50 day moving average price is $1,387.86 and its 200-day moving average price is $1,370.18. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The firm has a market capitalization of $24.98 billion, a price-to-earnings ratio of 29.17, a price-to-earnings-growth ratio of 2.58 and a beta of 1.43.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping the consensus estimate of $12.76 by $0.60. The company had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm’s revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.